Company / Operating Income per Share
Caris Life Sciences, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.24
FY2025
5-year range
-$9.15 / $1.24
FY2023-FY2025
Trend
+117.1%
vs FY2024
Sector context
#79 of 155
Health Care
What the data says
At $1.24, Caris Life Sciences, Inc.'s operating income per share ranks #79 of 155 in the Health Care sector. Improved from $-9.15 to $1.24 over the past 2 years.
Based on SEC 10-K filings.
1.24 in FY2025.
Improved from $-9.15 to $1.24 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 155 in Health CareTop 51% of 155This company $1.24 Sector average $4.18
▼
-70.4% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 117.1% year-over-year.
- Ranks #79 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.24 | +117.1% |
| FY2024 | -$7.24 | +20.8% |
| FY2023 | -$9.15 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026